Trials / Active Not Recruiting
Active Not RecruitingNCT06569784
Mass Balance Study of [14C]HSK31858 in Healthy Adult Male Chinese Subjects.
A Clinical Study on Absorption, Metabolism, and Excretion of [14C]HSK31858 in Healthy Adult Male Chinese Subjects - Mass Balance and Biotransformation of [14C]HSK31858 in Human.
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Xizang Haisco Pharmaceutical Co., Ltd · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a single-center, nonrandomized, and open design study to investigate the pharmacokinetics, mass balance, metabolism and excretion of HSK31858 in healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]HSK31858 | A single oral dose of 40 mg/120 μCi \[14C\]HSK31858 after fasting for at least 10 hours. |
Timeline
- Start date
- 2024-05-30
- Primary completion
- 2024-07-02
- Completion
- 2024-10-30
- First posted
- 2024-08-26
- Last updated
- 2024-08-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06569784. Inclusion in this directory is not an endorsement.